Global Gene Silencing Market 2026–2030 expanding with RNA-based therapies

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Gene Silencing Market By The End Of 2030?

The gene silencing market has experienced substantial growth in recent years. It is anticipated to increase from $6.69 billion in 2025 to $7.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This historical expansion can be attributed to several factors, including advancements in molecular biology research, the discovery of RNA interference mechanisms, an increase in academic research funding, a rise in genetic disease studies, and enhanced pharmaceutical research and development spending.

The gene silencing market is projected for swift expansion in the coming years, reaching a valuation of $12.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is fueled by several factors, including the expansion of gene therapy pipelines, an increasing need for targeted therapeutics, broader applications of CRISPR technology, heightened clinical trial engagement, and the creation of advanced gene editing instruments. Significant trends anticipated for this period encompass the wider acceptance of RNA interference technologies, greater utilization of CRISPR-based gene silencing, broader therapeutic gene targeting, an elevated emphasis on precision medicine applications, and a surge in investment within genetic research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

What Primary Drivers Are Shaping The Development Of The Gene Silencing Market?

The increasing occurrence of genetic conditions is anticipated to fuel the expansion of the gene silencing market in the future. These disorders are defined as medical ailments stemming from irregularities in a person’s DNA. Their identification is growing, thanks to advancements in diagnostic methods, greater public understanding, and wider availability of genetic screening. The surge in genetic disorders is attributed to increasing parental age, which heightens the likelihood of genetic mutations being inherited by children. Gene silencing presents a promising method for addressing genetic disorders by specifically deactivating the expression of defective or pathogenic genes. As an illustration, in August 2023, Down Syndrome UK, a charity based in the UK, reported that Down syndrome impacts an estimated 40,000 people in the UK, with roughly 1 in every 800 babies being born with the condition. Consequently, the growing incidence of genetic disorders is propelling the expansion of the gene silencing market.

Which Segment Classifications Shape The Gene Silencing Market?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

How Are Trends Impacting The Gene Silencing Market?

Major companies operating in the gene silencing market are focusing on developing innovative technologies, such as small interfering RNA (siRNA), to enhance precision and efficacy in gene therapy. Small interfering RNA (siRNA) refers to a type of RNA molecule that plays a critical role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, preventing the production of disease-causing proteins. For instance, in October 2024, Judo Bio Inc., a US-based biotechnology company, launched siRNA, a next-generation drug utilizing small interfering RNA (siRNA) to silence genes. The unique features of this drug include proprietary delivery systems such as lipid nanoparticles or conjugated ligands that ensure efficient uptake by specific cells or tissues and AI-driven platforms that accelerate the identification of viable gene targets.

Which Companies Are Expanding Their Footprint In The Gene Silencing Market?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Read the full gene silencing market report here:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

How Does The Gene Silencing Market Perform Across Major Global Regions?

North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Silencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp

Browse Through More Reports Similar to the Global Gene Silencing Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795